EMEA-000402-PIP03-17-M03

Key facts

Invented name
Vimpat
Active substance
lacosamide
Therapeutic area
Neurology
Decision number
P/0059/2019
PIP number
EMEA-000402-PIP03-17-M03
Pharmaceutical form(s)
  • Film-coated tablet
  • Syrup
  • Solution for infusion
Condition(s) / indication(s)
Treatment of generalised epilepsy and epileptic syndromes
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
UCB Pharma S.A.

Tel.  + 353 14632371
E-mail: UCBCares.IE@ucb.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating